Monte Rosa Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Hi everyone, good afternoon. I'm Ellie Merle, one of the Biotech Analysts at Barclays. Very happy to have Monte Rosa here with us today at the Barclays 28th annual Global Healthcare Conference here in Miami. Joining us from Monte Rosa is Philip Jenko, the Chief Medical Officer.
Philip, thank you so much for joining us today.
Thanks for having me.
Questions & Answers
You guys have a very exciting platform technology, one that I think deserves a lot more attention with molecular glues. Maybe before we jump into the specific programs, can you provide an overview of your platform technology and why this has potential to say reach previously undruggable targets and the advantages of, say, molecular glues and compare that to heterobisfunctional degraders.
So I might
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
